newsfilter
← Latest News
GlobeNewswire·

Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development

Highlights Collaboration aims to accelerate precision oncology research in AustraliaCombines Fortrea’s experience in oncology clinical trials with Omico’s Precision Oncology Screening Platform Enabling Clinical Trials